Skip to main navigation Skip to search Skip to main content

ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial

  • C Ferme
  • , J Thomas
  • , P Brice
  • , O Casasnovas
  • , A Vranovsky
  • , S Bologna
  • , Elly Lugtenburg
  • , R Bouabdallah
  • , P Carde
  • , C Sebban
  • , H Eghbali
  • , G Salles
  • , GW van Imhoff
  • , A Thyss
  • , EM Noordijk
  • , O Reman
  • , MLM Lybeert
  • , M Janvier
  • , M Spina
  • , B Audhuy
  • JMM Raemaekers, R Delarue, B Anglaret, O de Weerdt, Z Marjanovic, R Tersteeg, D de Jong, J Briere, M Henry-Amar

Research output: Contribution to journalArticleAcademicpeer-review

40 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)45-55
Number of pages11
JournalEuropean Journal of Cancer
Volume81
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC OR-01

Cite this